Belite Bio, Inc Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
Belite Bio, Inc (BLTE) had Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs of $1.84 million as of 2022-04-28, per its 20-F filed 2025-03-17.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts · last filed 2025-03-17
- 2022-04-28: Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs $1.84M.
| Period end | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs |
|---|---|
| 2022-04-28 | $1.84M 20-F · filed 2025-03-17 |